相关实验视频
Updated: Jul 17, 2025
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
139
拜卡林通过抑制miR-125a来缓解COPD中的气道炎症
1Department of General Medical, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, 030032, China.
Applied biochemistry and biotechnology
|September 1, 2023
概括
贝卡林可以减少烟雾引起的细胞损伤和支气管细胞的炎症. 它通过抑制miR-125a来实现这一目标,为慢性阻塞性肺病 (COPD) 提供了潜在的治疗策略.
科学领域:
- 肺部病理学 肺部病理学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 香烟烟雾提取物 (CSE) 诱导人类支气管上皮细胞 (16HBE) 的亡和炎症,模拟慢性阻塞性肺病 (COPD).
- 贝卡林是一种潜在的治疗剂,但其对CSE诱导的细胞损伤和炎症反应的影响需要阐明.
研究的目的:
- 研究Baicalin在16HBE细胞中对CSE诱导的亡和炎症的保护作用.
- 在CSE诱导的COPD模型中探索涉及miR-125a的潜在机制.
主要方法:
- 用CSE对16HBE细胞进行治疗,以建立COPD细胞模型.
- 用CCK-8和BrdU试验评估细胞增殖.
- 用TUNEL测定测量了亡,并量化了炎症性细胞因子 (IL-1β,IL-8,IL-6,TNF-α).
- 使用RT-QPCR分析了miR-125a表达,随后进行了miR-125a沉默实验.
主要成果:
- CSE显著降低了16HBE细胞增殖,增加了细胞亡和炎症性细胞因子释放.
- 拜卡林治疗逆转了这些CSE诱导的影响,减少了细胞亡和炎症.
- 贝卡林抑制了COPD模型中观察到的miR-125a的高表达. 沉默miR-125a模仿了Baicalin的保护作用,而它的过度表达则逆转了它们.
结论:
- 贝卡林显示出对人类支气管上皮细胞中CSE诱导的亡和炎症的保护作用.
- 巴伊卡林的作用机制包括抑制miR-125a的表达.
- 这些发现表明,Baicalin通过通过miR-125a调节减轻香烟烟雾引起的肺损伤,对COPD具有治疗潜力.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
244
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
244
01:17Drugs Used in Lower Respiratory Disorders: Overview
487
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
487
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:20Asthma: Pathogenesis and Management
442
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
442
01:20COPD: Pathogenesis and Clinical Features
337
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
337
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
342
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
342